AI assistant
RSA INSURANCE GROUP LIMITED Director's Dealing 2021
4719_dirs_2021-03-03_34541ba5-64e0-4edf-b416-3a4b72924a1a.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 0872R
RSA Insurance Group PLC
03 March 2021
RSA Insurance Group plc
("the Company")
Transactions in shares by Persons Discharging Managerial Responsibility ("PDMRs")
Ordinary Shares of £1.00 each
3 March 2021
The Company announces the following changes to the interests of PDMRs in the Company's Ordinary Shares of £1.00 each ("Shares").
On 2 March 2021 the nil cost Conditional Awards over Shares granted on 2 March 2018 and 2 September 2019 under the terms of the RSA Performance Share Plan 2014 ("PSP") to the following PDMRs vested as shown in the table below. On 2 and 3 March additional shares were sold as shown in the table below.
| Name | No. of Performance Shares vested | No. of Dividend Equivalent Shares on Performance Shares | No. of Bonus Deferral Shares Vested |
No. of Dividend Equivalent Shares on Bonus Deferral Shares | No. of Restricted Shares Vested | No. of Shares sold to cover statutory deductions |
Additional sale of Ordinary Shares | |
| Stephen Hester1 | 188,824 | 15,741 | 79,120 | 6,596 | - | 136,843 | - | |
| Scott Egan1 | 88,959 | 7,416 | 42,867 | 3,573 | - | 67,326 | - | |
| Martin Thompson | 55,412 | 4,619 | 32,702 | 2,726 | - | 51,253 | - | |
| Ralph Daals | 29,229 | 2,436 | 7,087 | 590 | - | 18,547 | 20,931 | |
| Charlotte Heiss | 23,997 | 2,000 | 5,367 | 447 | - | 14,997 | 17,637 | |
| William McDonnell | 31,517 | 2,627 | 15,450 | 1,288 | - | 23,987 | ||
| Karen Caddick | 19,508 | 509 | - | - | - | 9,437 | ||
| Charlotte Jones1,2, | 39,713 | 1,038 | - | - | 63,426 | 49,111 | ||
| Nathan Williams | 40,113 | 3,343 | 18,659 | 1,555 | - | 30,015 | 63,638 | |
| Kenneth Norgrove | 22,420 | 1,868 | 11,495 | 958 | - | 19,163 |
· Bonus Deferral Shares granted on 2 March 2018 relate to awards made in respect of 2017 as part of the Annual Bonus Plan.
· As the bid for RSA announced on 18 November 2020 fell within the performance period, it has impacted RSA's TSR. Therefore the Remuneration Committee has used its discretion under the PSP rules and approved Directors' Remuneration Policy to delay the final calculation for the TSR condition until there is clarity as to whether the bid will complete.
· The Dividend Equivalent Shares are added to the awards at vesting in accordance with the rules of the PSP and Directors' Remuneration Policy.
· Shares sold to cover statutory deductions were sold at a price of £6.770195 per share on 2 March 2021.
· Shares retained have been transferred to the Computershare nominee account operated by RSA as part of the share plan administration system.
· Additional shares sold, as indicated above, were sold at the prices shown in the individual forms which follow this summary page
Notes to table:
1 A two-year retention period applies to vested Performance Shares, excluding any sold to satisfy statutory deductions, in line with the Directors' Remuneration Policy.
2Awarded to compensate for awards forfeited on leaving previous employer, in accordance with the Directors' Remuneration Policy.
The forms required under the EU Market Abuse Regulation follow.
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Stephen Hester
b)
Position / status
Group Chief Executive
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 2 March 2023.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 188,824 |
d)
Aggregated information
- Aggregated volume
- Price
188,824
Nil
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 2 March 2023.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 15,741 |
d)
Aggregated information
- Aggregated volume
- Price
15,741
Nil
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 79,120 |
d)
Aggregated information
- Aggregated volume
- Price
79,120
Nil
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 6,596 |
d)
Aggregated information
- Aggregated volume
- Price
6,596
Nil
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 136,843 |
d)
Aggregated information
- Aggregated volume
- Price
136,843
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Scott Egan
b)
Position / status
CEO, UK and International
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 2 March 2023.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 88,959 |
d)
Aggregated information
- Aggregated volume
- Price
88,959
Nil
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 2 March 2023.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 7,416 |
d)
Aggregated information
- Aggregated volume
- Price
7,416
Nil
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 42,867 |
d)
Aggregated information
- Aggregated volume
- Price
42,867
Nil
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 3,573 |
d)
Aggregated information
- Aggregated volume
- Price
3,573
Nil
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 67,326 |
d)
Aggregated information
- Aggregated volume
- Price
67,326
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Martin Thompson
b)
Position / status
CEO, Canada
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 55,412 |
d)
Aggregated information
- Aggregated volume
- Price
55,412
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 4,619 |
d)
Aggregated information
- Aggregated volume
- Price
4,619
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 32,702 |
d)
Aggregated information
- Aggregated volume
- Price
32,702
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 2,726 |
d)
Aggregated information
- Aggregated volume
- Price
2,726
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 51,253 |
d)
Aggregated information
- Aggregated volume
- Price
51,253
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Ralph Daals
b)
Position / status
Group Chief Auditor
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 29,229 |
d)
Aggregated information
- Aggregated volume
- Price
29,229
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 2,436 |
d)
Aggregated information
- Aggregated volume
- Price
2,436
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 7,087 |
d)
Aggregated information
- Aggregated volume
- Price
7,087
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 590 |
d)
Aggregated information
- Aggregated volume
- Price
590
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 18,547 |
d)
Aggregated information
- Aggregated volume
- Price
18,547
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Tatjana Daals
b)
Position / status
PCA of Ralph Daals, Group Chief Auditor
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.77 | 20,931 |
d)
Aggregated information
- Aggregated volume
- Price
20,931
£6.77
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Charlotte Heiss
b)
Position / status
Group General Counsel and Company Secretary
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 23,997 |
d)
Aggregated information
- Aggregated volume
- Price
23,997
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 2,000 |
d)
Aggregated information
- Aggregated volume
- Price
2,000
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 5,367 |
d)
Aggregated information
- Aggregated volume
- Price
5,367
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 447 |
d)
Aggregated information
- Aggregated volume
- Price
447
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 14,997 |
d)
Aggregated information
- Aggregated volume
- Price
14,997
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.769585 | 17,637 |
d)
Aggregated information
- Aggregated volume
- Price
17,637
£6.769585
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
William McDonnell
b)
Position / status
Group Chief Risk Officer
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 31,517 |
d)
Aggregated information
- Aggregated volume
- Price
31,517
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 2,627 |
d)
Aggregated information
- Aggregated volume
- Price
2,627
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 15,450 |
d)
Aggregated information
- Aggregated volume
- Price
15,450
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 1,288 |
d)
Aggregated information
- Aggregated volume
- Price
1,288
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
| XLON London Stock Exchange |
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 23,987 |
d)
Aggregated information
- Aggregated volume
- Price
23,987
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Karen Caddick
b)
Position / status
Group & UK HR Director
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 19,508 |
d)
Aggregated information
- Aggregated volume
- Price
19,508
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 509 |
d)
Aggregated information
- Aggregated volume
- Price
509
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 9,437 |
d)
Aggregated information
- Aggregated volume
- Price
9,437
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Charlotte Jones
b)
Position / status
Group Chief Financial Officer
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a two-year retention period which ends on 2 March 2023.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 39,713 |
d)
Aggregated information
- Aggregated volume
- Price
39,713
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting. The vested shares are subject to a two-year retention period which ends on 2 March 2023.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 1,038 |
d)
Aggregated information
- Aggregated volume
- Price
1,038
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Restricted Share awards granted on 2 September 2019 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014. The vested shares are subject to a six-month retention period which ends on 2 September 2021.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 63,426 |
d)
Aggregated information
- Aggregated volume
- Price
63,426
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 49,111 |
d)
Aggregated information
- Aggregated volume
- Price
49,111
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Nathan Williams
b)
Position / status
Group Underwriting Director
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 40,113 |
d)
Aggregated information
- Aggregated volume
- Price
40,113
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 3,343 |
d)
Aggregated information
- Aggregated volume
- Price
3,343
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 18,659 |
d)
Aggregated information
- Aggregated volume
- Price
18,659
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 1,555 |
d)
Aggregated information
- Aggregated volume
- Price
1,555
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on 2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 30,015 |
d)
Aggregated information
- Aggregated volume
- Price
30,015
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.766258 | 57,611 |
d)
Aggregated information
- Aggregated volume
- Price
57,611
£6.766258
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.776 | 6,027 |
d)
Aggregated information
- Aggregated volume
- Price
6,027
£6.776
e)
Date of the transaction
3 March 2021
f)
Place of the transaction
XLON London Stock Exchange
1.
Details of PDMR / Person Closely Associated ("PCA")
a)
Name
Kenneth Norgrove
b)
Position / status
CEO RSA Scandinavia
c)
Initial notification / amendment
Initial Notification
2.
Details of the issuer
a)
Name
RSA Insurance Group plc
b)
LEI
549300HOGQ7E0TY86138
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Performance Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 22,420 |
d)
Aggregated information
- Aggregated volume
- Price
22,420
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Performance Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 1,868 |
d)
Aggregated information
- Aggregated volume
- Price
1,868
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Bonus Deferral Share award granted on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 11,495 |
d)
Aggregated information
- Aggregated volume
- Price
11,495
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Vesting of Dividend Equivalent Share award granted as part of the Bonus Deferral Share award on 2 March 2018 over Ordinary Shares under the terms of the RSA Performance Share Plan 2014 at nil cost and added to that award at vesting.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| NIL | 958 |
d)
Aggregated information
- Aggregated volume
- Price
958
NIL
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Ordinary Shares of £1 each
ISIN: GB00BKKMKR23
b)
Nature of the transaction
Sale of shares to cover statutory deductions on share awards vested on2 March 2021 under the RSA Performance Share Plan 2014.
c)
Price(s) and volume(s)
| Price(s) per unit | Volume(s) |
| £6.770195 | 19,163 |
d)
Aggregated information
- Aggregated volume
- Price
19,163
£6.770195
e)
Date of the transaction
2 March 2021
f)
Place of the transaction
XLON London Stock Exchange
Enquiries to:
Christopher Smyth, Deputy Group Company Secretary
RSA Insurance Group plc
Tel: +44 (0) 20 7111 7000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHKZGGFVFZGMZM